← Leaderboards
Mary K Wloch
Vical, Inc.
$258,937
Attributed
$258,937
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$258,937 · 1
By mechanism
R01$258,937 · 1
Top collaborators
No co-investigators on record.
Most similar at Vical, Inc.
Same institution · by research overlap
- Peter M. Hobart$2,818,910
- Peggy Lalor$3,895,660
- Sean M. Sullivan$1,999,533
- David C. Kaslow$2,089,603
- Ronald B Moss$1,047,535
Others in their field
Top investigators on “Antigen Antibody Reaction”
- Catherine C Hedrick · Augusta University$20,084,915
- Hidde L Ploegh · Boston Children'S Hospital$14,915,062
- Michael B Brenner · Brigham And Women'S Hospital$12,889,077
- Duane R. Wesemann · Brigham And Women'S Hospital$12,705,565
- Gabriel D Victora · Rockefeller University$12,395,724
- Keri, Hammel · The Emmes Company, Llc$11,064,901
Research focus
Antigen Antibody ReactionClinical Trial Phase IClinical Trial Phase IiEnzyme Linked Immunosorbent AssayLeukocyte Activation /TransformationTechnology /Technique DevelopmentT Lymphocyte